Twist Bioscience (TWST) Raw Materials (2018 - 2026)

Twist Bioscience (TWST) has reported Raw Materials for 9 consecutive years, with $25.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Raw Materials rose 78.74% year-over-year to $25.5 million; the TTM figure through Mar 2026 stood at $25.5 million (up 78.74% YoY), while the FY2025 annual figure was $20.2 million, up 16.6% from the prior year.
• Raw Materials climbed to $25.5 million in Q1 2026 per TWST's latest filing, from $24.7 million in the prior quarter.
• Across five years, Raw Materials topped out at $33.6 million in Q1 2023 and bottomed at $14.3 million in Q1 2025.
• Historically, Raw Materials has averaged $24.7 million across 5 years, with a median of $24.7 million in 2025.
• Annual changes were most pronounced in 2022 — Raw Materials soared 180.8% — and 2024, when it tumbled 35.92%.
• Twist Bioscience's Raw Materials stood at $33.6 million in 2022, then slipped by 29.22% to $23.8 million in 2023, then slumped by 32.51% to $16.0 million in 2024, then jumped by 53.86% to $24.7 million in 2025, then rose by 3.58% to $25.5 million in 2026.
• Business Quant data shows TWST's Raw Materials at $25.5 million in Q1 2026, $24.7 million in Q4 2025, and $20.2 million in Q3 2025.